International Journal of Pharmaceutical Investigation logo
Article

Development of time controlled chronomodulated tablet with swelling and rupturable layers: Optimization of factors influencing lag‑time and drug release

1, 1★, 1, 1, 1★ Corresponding author

  1. 1Department of pharmaceutics, C. U. Shah College of Pharmacy & Research, Wadwan, Gujarat, INDIA.

CORRESPONDENCE

Rishad R Jivani

Department of pharmaceutics, C. U. Shah College of Pharmacy & Research, Wadwan, Gujarat, INDIA.

hellorishad@yahoo.com

Volume 2, Issue 4 · pp. 208-212 · 2013 · DOI: 10.4103/2230-973X.107005

ABSTRACT

Introduction: A tablet system consisting of cores coated with two layers of swelling and rupturable coatings was prepared and evaluated as time controlled chronomodulated tablet.Materials and Methods: Cores containing Montelukast sodium as model drug were prepared by direct compression and then coated sequentially with an inner swelling layer containing a HPMC E 5 and an outer rupturable layer of Eudragit RL/RS (1:1). A three‑factor, two‑level, full factorial design was used to investigate the influence of amount of HPMC E 5 and Eudragit RL/RS (1:1) on the responses, i.e., lag time to release and time required for 80% of drug to releases. The dissolution tests were studied using the USP paddle method at 50 rpm in 0.1 N HCL for 2 hr and than in phosphate buffer pH 6.8.Result: The lag time of the drug release decreased by increasing the inner swelling layer and increased by increasing the rupturing layer level.Conclusion: The results obtain from present study suggest that swelling come reputable coating approach gives desire drug release after lag time.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Desai, M., Jivani, R. R., Patel, L. D., Jivani, N. P., & Sonagara, B. (2013). Development of time controlled chronomodulated tablet with swelling and rupturable layers: Optimization of factors influencing lag‑time and drug release. International Journal of Pharmaceutical Investigation, 2(4), 208-212. https://doi.org/10.4103/2230-973X.107005

    Copyright and licence

    © 2013 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0